Pharma: Other News To Note

• Sanofi Pasteur, of Swiftwater, Pa., the vaccines division of Sanofi SA, said it filed a supplemental biologics license application for a quadrivalent formulation of its Fluzone (influenza virus vaccine). The filing was accepted by the FDA for full review, and an action date is anticipated in the second quarter of 2013.